- Brands
- Top 50
- Specials & Promos
- Sports Nutrition
- Prohormones/Support
- Health & Vitamins
- Stacks
- What's New
Are you finding your current pre-workout isn't quite cutting it? If you're looking to take your workouts to The Edge of Insanity, you gotta try Edge of Insanity from Psycho Pharma. This pre-workout provides intense energy, laser like foucs, and huge pumps, it brings you right up to the edge of insanity without pushing you over.
To assess tolerance mix ½ scoop of Edge of Insanity with 8 oz of cold water. Once tolerance has been assessed, mix 1 scoop of Edge of Insanity with 8 oz of cold water and consume 15 to 30 minutes before exercise. Do not consume Edge of Insanity within 4 hours of bedtime. Do not take any other products that contain caffeine or any other stimulants while taking Edge of Insanity.
Serving Size: 1 Scoop (10g)
Servings Per Container: 30
Psycho Endurance Vascularity & Pump Blend
Beta Alanine 3.2g
GlycerPump (65% Glycerol Powder) 2.5g
Agmatine Sulfate 500mg
Razor's Edge Focus
Kanna 20:1 Extract (Sceletium Tortuosum) 750mg
Caffeine Anhydrous 350mg
Theophylline Anhydrous 35mg
Theobromine 20mg
Yohimbine HCI 5mg
Rauwolscine 98% 4mg
Bioperine 5mg
*Daily Values based on a 2,0000 calorie diet
*Daily Value Not Established
Other Ingredients: Malic Acid, Calcium Silicate, Silicon Dioxide, Citric Acid, Natural & Artificial Flavors, Sucralose, Acesulfame Potassium, FD&C Red #40
Do not exceed recommended dose. Consult your physician before using this dietary supplement. Do not use if you are at risk of or being treated for high blood pressure, kidney, thyroid, or psychiatric disease, difficulty in urinating, prostate enlargement, anxiety, depression, seizure disorder, or stroke.
National Center for Biotechnology Information. PubChem Database. Yohimbine hydrochloride, CID=6169, https://pubchem.ncbi.nlm.nih.gov/compound/Yohimbine-hydrochloride
Terburg D, Syal S, Rosenberger LA, et al. Acute effects of Sceletium tortuosum (Zembrin), a dual 5-HT reuptake and PDE4 inhibitor, in the human amygdala and its connection to the hypothalamus. Neuropsychopharmacology. 2013;38(13):2708–2716. doi:10.1038/npp.2013.183
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828542/